Spotlight on Mobocertinib (TAK-788) in NSCLC with EGFR Exon 20 Insertion Mutations

Zhang, SS; Zhu, VW

Zhu, VW (corresponding author), Univ Calif Orange, Irvine Sch Med, Dept Med, 200 S Manchester Ave,Suite 410, Orange, CA 92868 USA.

LUNG CANCER-TARGETS AND THERAPY, 2021; 12 (): 61

Abstract

The EGFR exon 20 insertion (EGFRex20ins) mutations are the third most common EGFR mutations seen in non-small cell lung cancer (NSCLC), constituting u......

Full Text Link